Literature DB >> 16084884

Treatment preferences and trade-offs for ovulation induction in clomiphene citrate-resistant patients with polycystic ovary syndrome.

Neriman Bayram1, Madelon van Wely, Fulco van der Veen, Patrick M M Bossuyt, Pythia Nieuwkerk.   

Abstract

OBJECTIVE: To investigate patient preferences and trade-offs for laparoscopic electrocautery of the ovaries relative to ovulation induction with recombinant FSH (rFSH) in patients with clomiphene citrate (CC)-resistant polycystic ovary syndrome (PCOS).
DESIGN: Assessment of preferences and trade-offs in a randomized controlled trial.
SETTING: Academic hospital. PATIENT(S): Thirty-two CC-resistant patients with PCOS who had been randomly assigned to either laparoscopic electrocautery of the ovaries or ovulation induction with rFSH and 32 control patients with PCOS under treatment with CC. INTERVENTION(S): Preference for laparoscopic electrocautery relative to rFSH was established during an interview. Trade-offs between treatment burden and effectiveness were evaluated by varying hypothetical pregnancy rates after laparoscopic electrocautery until patients switched in their initial preference. MAIN OUTCOME MEASURE(S): Preference for laparoscopic electrocautery of the ovaries; trade-off between burden and effectiveness of treatment. RESULT(S): The majority of the patients would prefer electrocautery of the ovaries over ovulation induction with rFSH if both treatment strategies resulted in similar pregnancy rates. However, most patients were willing to trade off their preference for increased effectiveness: the percentage of patients who preferred electrocautery over rFSH sharply declined when the difference in hypothetical pregnancy rates was more than 5% in favor of rFSH. CONCLUSION(S): Patients with polycystic ovary syndrome are well able to express an informed preference for laparoscopic electrocautery of the ovaries or ovulation induction with rFHS. Preferences are guided by features of the respective treatments but seem to be dominated by their effectiveness and safety.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16084884     DOI: 10.1016/j.fertnstert.2005.02.026

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  6 in total

1.  Incorporating patient preference into the management of infertility in women with polycystic ovary syndrome.

Authors:  Ugochi C Okoroafor; Emily S Jungheim
Journal:  Patient Prefer Adherence       Date:  2012-05-24       Impact factor: 2.711

2.  Willingness to pay and conjoint analysis to determine women's preferences for ovarian stimulating hormones in the treatment of infertility in Spain.

Authors:  A Palumbo; P De La Fuente; M Rodríguez; F Sánchez; J Martínez-Salazar; M Muñoz; J Marqueta; J Hernández; O Espallardo; C Polanco; S Paz; L Lizán
Journal:  Hum Reprod       Date:  2011-05-10       Impact factor: 6.918

3.  Women's perspectives on ovulation induction with or without IUI as treatment for normogonadotrophic anovulation: a discrete choice experiment.

Authors:  N S Weiss; A M F Schreurs; F van der Veen; P G A Hompes; C B Lambalk; B W Mol; M van Wely
Journal:  Hum Reprod Open       Date:  2017-11-23

4.  The perspective of women with an increased risk of OHSS regarding the safety and burden of IVF: a discrete choice experiment.

Authors:  S C Braam; J P de Bruin; B W J Mol; M van Wely
Journal:  Hum Reprod Open       Date:  2020-02-24

5.  The M-OVIN study: does switching treatment to FSH and / or IUI lead to higher pregnancy rates in a subset of women with world health organization type II anovulation not conceiving after six ovulatory cycles with clomiphene citrate - a randomised controlled trial.

Authors:  Marleen J Nahuis; Nienke S Weiss; Fulco van der Veen; Ben Willem J Mol; Peter G Hompes; Jur Oosterhuis; Nils B Lambalk; Jesper M J Smeenk; Carolien A M Koks; Ron J T van Golde; Joop S E Laven; Ben J Cohlen; Kathrin Fleischer; Angelique J Goverde; Marie H Gerards; Nicole F Klijn; Lizka C M Nekrui; Ilse A J van Rooij; Diederik A Hoozemans; Madelon van Wely
Journal:  BMC Womens Health       Date:  2013-10-25       Impact factor: 2.809

6.  Ovarian drilling in polycystic ovary syndrome: Long term pregnancy rate.

Authors:  E Debras; H Fernandez; M-E Neveu; X Deffieux; P Capmas
Journal:  Eur J Obstet Gynecol Reprod Biol X       Date:  2019-08-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.